Literature DB >> 3236300

IgA containing immune complexes and hematuria in ankylosing spondylitis. A prospective longitudinal study.

A J Peeters1, A W van den Wall Bake, G A van Albada-Kuipers, M L Westedt, R Brand, F C Breedveld, L A van Es, A Cats.   

Abstract

The occurrence of circulating immune complexes containing IgA (IgA-IC) was studied in groups of patients with ankylosing spondylitis (AS) selected for the presence or absence of hematuria. In studies done with 4 kinds of assays, IgA-IC were found more frequently and in higher titers in the 18 patients with AS with hematuria than in the 40 patients with AS without hematuria. Comparison of clinical indices of disease activity in these patient groups showed that the disease was more active in patients with AS with hematuria. Our findings confirm those made in a previous retrospective study on the relation between hematuria and circulating IgA-IC in AS and suggest that circulating IgA-IC play a role in the pathogenesis of hematuria in AS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3236300

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  A handicap in treatment and follow-up of ankylosing spondylitis: sports hematuria.

Authors:  Ozden Ozyemişci; Gülçin Kaymak Karataş; Sebnem Celikmez; Işil Babaoğlu
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

2.  Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes.

Authors:  A J Peeters; A W van den Wall Bake; M R Daha; F C Breeveld
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

3.  Immune complexes in ankylosing spondylitis.

Authors:  I L MacLean; J R Archer; M I Cawley; B L Kidd; B P O'Hara; F S Pegley; P W Thompson
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.